This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Geoffrey Hamilton-Fairley
Operating Partner
Geoffrey Hamilton-Fairley is an experienced Chairman, NED and investment advisor with a track record of leading companies at different stages of development from start-ups through to sale and IPO.
His entrepreneurial career started in 1982, founding a number of companies in Public Relations, Technology, Advertising and Music & Personality management backed by The Abingdon Management Company Limited, where he subsequently became sole owner having acquired Abingdon from its institutional shareholders. Abingdon had a number of quoted and unquoted investments including a Unit Trust, Foretronic (a technology company that introduced the magnetic data strip on the back of credit cards), TVS (ITV franchise for the South of England), and a significant property portfolio in the UK and abroad.
Returning to his medical roots, Geoffrey developed and guided Oncimmune, a company pioneering technologies to enable early cancer detection, from a Nottingham University start-up through to a successful IPO in May 2016, with total funds raised of £62m. During this period he co-authored numerous scientific and health economic publications.
He now acts as an advisor to leading technology and healthcare funds, advising investment teams, specific due diligence projects, monitoring investments as a director and mentoring CEOs.